Filed Under:Health Insurance, Individual Health

PwC Survey: Drug Manufacturers Must Demonstrate Clinical, Economic Benefits of Products

Photo credit: vichie81
Photo credit: vichie81

A shift in consumer and provider preferences could hurt revenues for drug manufacturers that don’t speed efforts to demonstrate the clinical and economic benefits of their products, according to a new PricewaterhouseCoopers survey.

PwC, London, U.K., published this finding in a survey that explores how well health insurers and pharmaceutical companies work together using information about drug effectiveness in the care of patients. The phone survey of executives at 100 different health insurers uncovered the following:

Featured Video

Most Recent Videos

Prospects not listening to voice mail? Arrange a phone date

Provided by LIFEHEALTHPRO

Redesigning your phone life is more important than finding the “best words” for a voice mail in today’s culture.

Behind the scenes with Vicki Gunvalson [VIDEO]

Provided by LIFEHEALTHPRO

In this exclusive interview, Vicki Gunvalson shares how she built a $15 million a year annuity business by planning for...

Regulator: Market may need to reinvent LTCI

Provided by LIFEHEALTHPRO

Cioppa says Maine's governor wants to spur the creation of better products.

Dementia: It's more than Alzheimer's

Provided by LIFEHEALTHPRO

An association calls for policymakers to remember lesser-known neurodegenerative conditions.

Related resources

More Resources

Comments

Power your business with up-to-the-minute insurance news, analysis, and best practices from LifeHealthPro Daily eNewsletter – FREE.

Power your business with LifeHealthPro Daily eNewsletter – FREE.

Enter a valid email address.
Close
Nichole Morford

Nichole Morford
Managing Editor

Thank you for subscribing to LifeHealthPro Daily!

Check Out More eNewsletters Now! Close

Advertisement. Closing in 15 seconds.